LPL Financial
TNYA icon

LPL Financial’s Tenaya Therapeutics TNYA Stock Holding History

LPL Financial’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Buy
16,953
+5,500
+48% +$4.18K ﹤0.01% 6155
2026
Q1 		$7.93K Sell
11,453
-3,370
-23% -$2.49K ﹤0.01% 5936
2025
Q4 		$10.5K Sell
14,823
-7,530
-34% -$10.2K ﹤0.01% 5847
2025
Q3 		$36.2K Buy
+22,353
New +$22.5K ﹤0.01% 5676
2025
Q2 		– Sell
-12,553
Closed -$7.16K – 5683
2025
Q1 		$7.16K Buy
+12,553
New +$12.4K ﹤0.01% 5327

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's TNYA Position: Q2 2026 in Review

LPL Financial increased its Tenaya Therapeutics (TNYA) stake by 48% in Q2 2026, buying an estimated $4.18K and bringing the position to 16,953 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #6155.

LPL Financial first reported a position in TNYA in Q1 2025 and has held it in 5 quarters since. The position peaked at $36.2K in Q3 2025. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • LPL Financial held 16,953 shares of Tenaya Therapeutics worth $12.5K as of Q2 2026.
  • LPL Financial bought 5,500 Tenaya Therapeutics shares in Q2 2026, an estimated $4.18K.
  • Tenaya Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6155 holding.
  • LPL Financial first reported a position in Tenaya Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • LPL Financial's Tenaya Therapeutics position peaked at $36.2K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.